BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 24051962)

  • 1. Measuring functional health among the elderly: development of the Japanese version of the World Health Organization Disability Assessment Schedule II.
    Tazaki M; Yamaguchi T; Yatsunami M; Nakane Y
    Int J Rehabil Res; 2014 Mar; 37(1):48-53. PubMed ID: 24051962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the World Health Organization Assessment Schedule II Chinese Traditional Version (WHODAS II CT) in persons with disabilities and chronic illnesses for Chinese population.
    Cheung MK; Hung AT; Poon PK; Fong DY; Li LS; Chow ES; Qiu ZY; Liou TH
    Disabil Rehabil; 2015; 37(20):1902-7. PubMed ID: 25495681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of traditional Chinese version of World Health Organization disability assessment schedule 2.0 36--item (WHODAS 2.0) in Taiwan: validity and reliability analyses.
    Chiu TY; Yen CF; Chou CH; Lin JD; Hwang AW; Liao HF; Chi WC
    Res Dev Disabil; 2014 Nov; 35(11):2812-20. PubMed ID: 25094056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. World Health Organisation Disability Assessment Schedule II: contribution to the Italian validation.
    Federici S; Meloni F; Mancini A; Lauriola M; Olivetti Belardinelli M
    Disabil Rehabil; 2009; 31(7):553-64. PubMed ID: 19191060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility, reliability, and validity of the Japanese version of the 12-item World Health Organization Disability Assessment Schedule-2 in preoperative patients.
    Ida M; Naito Y; Tanaka Y; Matsunari Y; Inoue S; Kawaguchi M
    J Anesth; 2017 Aug; 31(4):539-544. PubMed ID: 28378206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the 36-item and 12-item self-report World Health Organization Disability Assessment Schedule II (WHODAS-II) in individuals with autism spectrum disorder.
    Park SH; Demetriou EA; Pepper KL; Song YJC; Thomas EE; Hickie IB; Glozier N; Guastella AJ
    Autism Res; 2019 Jul; 12(7):1101-1111. PubMed ID: 31033250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the World Health Organization Disability Assessment Schedule II (WHODAS-II) in patients with multiple sclerosis.
    Magistrale G; Pisani V; Argento O; Incerti CC; Bozzali M; Cadavid D; Caltagirone C; Medori R; DeLuca J; Nocentini U
    Mult Scler; 2015 Apr; 21(4):448-56. PubMed ID: 25092769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinimetric properties of the World Health Organization Disability Assessment Schedule II in early inflammatory arthritis.
    Baron M; Schieir O; Hudson M; Steele R; Kolahi S; Berkson L; Couture F; Fitzcharles MA; Gagné M; Garfield B; Gutkowski A; Kang H; Kapusta M; Ligier S; Mathieu JP; Ménard H; Starr M; Stein M; Zummer M
    Arthritis Rheum; 2008 Mar; 59(3):382-90. PubMed ID: 18311751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disability in bipolar I disorder: the 36-item World Health Organization Disability Assessment Schedule 2.0.
    Guilera G; Gómez-Benito J; Pino Ó; Rojo E; Vieta E; Cuesta MJ; Purdon SE; Bernardo M; Crespo-Facorro B; Franco M; Martínez-Arán A; Safont G; Tabarés-Seisdedos R; Rejas J;
    J Affect Disord; 2015 Mar; 174():353-60. PubMed ID: 25553398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-cultural adaptation of the World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) for Hebrew-speaking subjects with and without hand injury.
    Marom BS; Carel RS; Sharabi M; Ratzon NZ
    Disabil Rehabil; 2017 Jun; 39(12):1155-1161. PubMed ID: 27291062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the World Health Organization Disability Assessment Schedule in people with severe mental disorders in rural Ethiopia.
    Habtamu K; Alem A; Medhin G; Fekadu A; Dewey M; Prince M; Hanlon C
    Health Qual Life Outcomes; 2017 Apr; 15(1):64. PubMed ID: 28381230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychometric properties of the world health organization disability assessment schedule II -12 Item (WHODAS II) in trauma patients.
    Abedzadeh-Kalahroudi M; Razi E; Sehat M; Asadi-Lari M
    Injury; 2016 May; 47(5):1104-8. PubMed ID: 26710706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The reliability and validity of the World Health Organization Disability Assessment Schedule (WHODAS-II) in stroke.
    Küçükdeveci AA; Kutlay Ş; Yıldızlar D; Öztuna D; Elhan AH; Tennant A
    Disabil Rehabil; 2013 Feb; 35(3):214-20. PubMed ID: 22671861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric properties of the twelve item World Health Organization Disability Assessment Schedule II (WHO-DAS II) in Spanish primary care patients with a first major depressive episode.
    Luciano JV; Ayuso-Mateos JL; Fernández A; Serrano-Blanco A; Roca M; Haro JM
    J Affect Disord; 2010 Feb; 121(1-2):52-8. PubMed ID: 19464735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the Utrecht Scale for Evaluation of Rehabilitation-Participation with the ICF Measure of Participation and Activities Screener and the WHO Disability Assessment Schedule II in persons with spinal cord injury.
    van der Zee CH; Post MW; Brinkhof MW; Wagenaar RC
    Arch Phys Med Rehabil; 2014 Jan; 95(1):87-93. PubMed ID: 24008052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self and proxy rating of quality of life in adults with intellectual disabilities: results from the DISQOL study.
    Schmidt S; Power M; Green A; Lucas-Carrasco R; Eser E; Dragomirecka E; Fleck M
    Res Dev Disabil; 2010; 31(5):1015-26. PubMed ID: 20478692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why sample selection matters in exploratory factor analysis: implications for the 12-item World Health Organization Disability Assessment Schedule 2.0.
    Gaskin CJ; Lambert SD; Bowe SJ; Orellana L
    BMC Med Res Methodol; 2017 Mar; 17(1):40. PubMed ID: 28283019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The World Health Organization Disability Assessment Scale, WHODAS II: reliability and validity in the measurement of activity and participation in a spinal cord injury population.
    Wolf AC; Tate RL; Lannin NA; Middleton J; Lane-Brown A; Cameron ID
    J Rehabil Med; 2012 Sep; 44(9):747-55. PubMed ID: 22854805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptation and validation of WHODAS 2.0 in patients with musculoskeletal pain.
    Silva C; Coleta I; Silva AG; Amaro A; Alvarelhão J; Queirós A; Rocha N
    Rev Saude Publica; 2013 Aug; 47(4):752-8. PubMed ID: 24346666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity limitation and participation restrictions of breast cancer patients receiving chemotherapy: psychometric properties and validation of the Chinese version of the WHODAS 2.0.
    Zhao HP; Liu Y; Li HL; Ma L; Zhang YJ; Wang J
    Qual Life Res; 2013 May; 22(4):897-906. PubMed ID: 22684528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.